Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 242

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 242
---
 2024, described in Note (1) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024.” (2)Represents the amortization of acquired intangible assets. See footnote (8) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024” section for details. (3)Represents the preliminary estimated expense recognized, in accordance with IFRS 2, for the excess of the fair value of the Company Shares issued over the book value of APx identifiable net assets at the date of the Business Combination (including the recognition of APx transaction costs, as described in Note (1) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Operations for the Year Ended June 30, 2024.” See footnote (5) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024” section. (4)To reflect the elimination of (a) interest income on marketable securities held in the Trust Account of APx and (b) the financial cost due to the change in the fair value of common shares of APx, subject to possible redemptions. (5)Represents the interest expense corresponding to intercompany loans agreements with OmnigenicsAI’s parent companies. See footnote (6) under “ Adjustments to Unaudited Pro Forma Combined Statement of Financial Position as of June 30, 2024” section for details. (6)To reflect the elimination of interest costs of borrowings provided by the Parent to OmnigenicsAI and Heritas Argentina, due to the capitalization of said liabilities described in footnote (7) under “ Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024.”The eliminated interest expense corresponds to the accrual in OmnigenicsAI’s combined financial statements corresponding to said capitalized loans. Adjustments to Unaudited Pro Forma Combined Consolidated Statement of Financial Position as of June 30, 2024 The pro forma notes and adjustments, based on preliminary estimates that could change materially as additional information is obtained, are as follows: (1)On December 4, 2024, the Company held an extraordinary general meeting of shareholders, during which 5,077,568 Public Shares were tendered for redemption at